PTGS2 and amyotrophic lateral sclerosis: The results were further validated by the increased expression of COX-2 in ALS-CSF compared to the normal and disease control, as determined by the western blot analysis (*p < 0.05 NC and NALS v/s ALS; Fig. 2b, c).